Latest information on COVID-19
Support teaching, research, and patient care.
Lawrence Tim Goodnough, MD is Professor of Pathology and Medicine (Hematology) in the Departments of Pathology and Medicine, at Stanford University. Dr. Goodnough received his medical degree in 1975 from the University of Pennsylvania, completed an internship and residency in Internal Medicine at the University of Alabama Hospitals in Birmingham, Alabama, and a fellowship in Hematology/Oncology at Case Western Reserve University (CWRU). He is board certified in Medicine, Hematology, and Oncology; and has an American College of Pathology Certification in Blood Banking. In his fellowship at CWRU, Dr. Goodnough specialized in coagulation research and later focused on Transfusion Medicine as a specialty that embraces the fields of Blood Banking, Coagulation, and Hematology.As a frequent lecturer, he has presented his work in more than 300 national and international forums. Dr. Goodnough has contributed more than 500 articles and 200 abstracts to the medical literature. He has a long-standing interest in devising strategies for patients to utilize alternatives to blood transfusion for the management of anemia, a concept more recently defined as Patient Blood Management.
Dr. Goodnough has a long-standing interest in alternatives to blood therapy. This includes the concept of antologous blood predonation before elective surgery; acute normovolemic hermodicution;erythropoietic agents to stimulate red blood cell production; pharmacologic strategies to reduce blood loss; artificial oxygen carriers; and re-evaluation of the transfusion trigger. <br/>Publications: <br/>Goodnough LT. Transfusion Medicine, in (Greer JP, Foerster J, Rodgers G et al, eds), Wintrobe's Clinical Hematology, 14th edition, Lippincott Williams & Wilkins, Philadelphia, PA, 2019;548-587.<br/>Goodnough LT. Iron deficiency and related disorders. In Wintrobe’s Clinical Hematology, 14th Edition (Greer JP, ed), Lippincott, Williams & Wilkins, Philadelphia, PA 2019;615-643.<br/>Goodnough LT. Oral vs intravenous iron therapy for postpartum anemia: a systematic review and meta-analysis. Am J of Obstetrics and Gynocology 2018; doi: https://doi.org/10.1016/j.ajog.2018.12.016.<br/>Goodnough LT. Anemia of Inflammation. Blood 2019;133:40-50.<br/>Goodnough LT. The effects of monoclonal anti-CD47 on red cells, compatibility testing and transfusion requirements in refractory acute myeloid leukemia. Transfusion 2019;59(7):2248-2254.<br/>Goodnough LT. Management of anemia in patients who decline blood transfusion. Amer J Hematol, 2018;1183-1191. <br/>Goodnough LT. Real-time clinical decision support decreases inappropriate plasma transfusion. AJCP 2017;148:154-160.<br/>Goodnough LT. A standardized approach for transfusion medicine support in patients with morbidly adherent placenta. Anesth & Analg 2017;125:603-608.<br/>Goodnough LT. Patient blood management bundles to facilitate implementation. Trans Med Rev 2017;31:62-71.<br/>Goodnough LT. Zika virus and patient blood management. Anesth & Analg 2017;124:282-289.<br/>Goodnough LT. Simplified international recommendations for the implementation of patient blood management. Perioperative Medicine 2017;6:5-7.<br/>Goodnough LT. Management of anemia in patients with congestive heart failure. Am. J. Hematol 2017;92:88–93.<br/>Goodnough LT. How I train specialists in transfusion medicine. Transfusion 2016;56(12):2923-2933.<br/>Goodnough LT. How do I use clinical decision support to improve red blood cell utilization. Transfusion 2016;56(10):2406-2411.